Archive

  • Eiopa's paper is a significant step forward for mass lapse reinsurance across Europe

    12 November 2024

    Last week's consultation paper from the EU's insurance authority will help drive the industry in the right direction, argues Luca Tres

  • Lapse risk and capital management strategies: rewriting the script

    04 July 2023

    Mass lapse risk has returned to haunt European life insurers, prompted a rethink of the approach to risk and capital management, as Luca Tres explains in the second of this two-part series

  • Lapse risk and capital management strategies: back in the spotlight

    27 June 2023

    Mass lapse risk has returned to haunt European life insurers, prompted a rethink of the approach to risk and capital management, as Luca Tres explains in the first of this two-part series

  • Legacy life consolidator cheered by deal prospects in 2022

    18 January 2022

    Athora's group chief risk officer Lukas Ziewer explains why

  • Legacy life books: targeted approaches to de-risking and optimisation

    17 January 2022

    In the second of two articles, Luca Tres reviews how a targeted risk transfer strategy can help life insurers better manage their legacy books - and looks to the future of legacy life de-risking

  • Legacy life books: a proactive approach

    10 January 2022

    In the first of two articles, Luca Tres discusses the strategies available to life insurers facing the challenges of high capital intensity and low profitability in their life legacy business

  • The alternative in life

    03 June 2021

    Luca Tres has been a pioneer in the development of the life ILS markets. As he begins a new role at Guy Carpenter, he talks to Christopher Cundy about the past and future at the intersection of re/insurance and capital markets

  • Genetic testing risks go under the microscope

    03 February 2021

    Do life insurers really face the risk of adverse selection from customers that have taken predictive genetic tests? Academics think not, and insurers and policyholders could indeed benefit from wider use of genetic testing, as Paul Walsh reports

  • A capital management toolkit for life re/insurers

    14 March 2019

    Paul Fulcher and Luca Tres describe the pros and cons of 10 techniques and solutions available to European life insurers under Solvency II to help manage capital

  • IFRS 17 earnings recognition: challenges, opportunities and innovations

    21 June 2018

    Luca Tres and Adam Robinson discuss IFRS 17 and its earning recognition criteria from a capital markets and insurance practitioner's perspective, and consider the challenges and the opportunities this presents